Congratulations to Gentrics Rotation Student Zaria Contejean who has just received a Ford Predoctoral Fellowship from National Academies of Science, Engineering and Medicine for her PhD studies!
Please join us in congratulating Professor Anna Gloyn as the American Diabetes Association’s recipient of the 2022 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality. This is one of the highest honors bestowed by the ADA. Anna will have a plenary lecture at the ADA in New Orleans, June 3-7, 2022.
On behalf of Drs. Romina Bevacqua, Ryan Hart, and Julie Sneddon, co-organizers of the Golden State Islet Seminars series, you are invited to:
Research in Progress Seminars (via Zoom) Friday, March 4th, from 12:00 PM-1:00 PM
Seth Andrew Sharp, PhD (Gloyn Lab)
"Genetic prediction and from birth screening of type 1 diabetes and related autoimmunity"
We are excited to welcome Dr. Seth Sharp to the Translational Genomics of Diabetes Lab! He joins us as a new Post-doc having trained at the University of Exeter with Drs. Richard Oram and Michael Weedon.
Welcome to Stanford University Seth!
On international women’s day in science (February 11th 2022) we celebrate the many female collaborators we have around the world and are thankful for those we have the pleasure of working with on a day-to-day basis in the Translational Genomics of Diabetes Lab #WomeninScience
Thank you to all our male allies who support us, but more work needs to be done by all to ensure that we do not miss out on 50% of the talent in science.
To learn about our new team members, please click on their names:
To learn about the bioBUDS, please click below:
Congratulations Alok and Grace on your new positions your friends in the Translational Genomics of Diabetes Lab wish you the very best in your new roles. Look forward to continued collaborations.
Congratulations to Dr Krentz on her recent publication in The Lancet Diabetes & Endocrinology. In celebration of the centenary of the discovery of insulin, Drs. Krentz, Shea, Huising and Shaw highlight current progress towards a regenerative medicine and tissue engineering approach for type 1 diabetes treatment. https://www.sciencedirect.com/science/article/pii/S2213858721001704
Congratulations to Dr Nicole Krentz!
Dr Krentz has been awarded an Maternal Child Health Research Institute (MCHRI) Post-doctoral award for her research on the role of the transcription factor RREB1 in adipose tissue development and function. Well done Nicole!!
American Diabetes Association (ADA) & European Association for the Study of Diabetes (EASD) Precision Medicine Initiative Conference April 2021
Anna Gloyn presented on behalf of the Precision Diagnostics for Monogenic Diabetes Working Group the current status in their systematic review for the second consensus report with her co-chair Dr Katharine Owen (Oxford).
ALINA POLLNER JOINS THE TRANSLATIONAL GENOMICS OF DIABETES LAB AS A BIOX-SUMMER STUDENT
The TGD lab is excited to welcome Alina Pollner to the team! Alina is currently a first-year undergraduate student at Stanford studying human biology and math. As of this week she is now a member of the Bio-X Undergraduate Summer Research Program (https://biox.stanford.edu/research/undergraduate-research) for the summer of 2021, and will be working on a project to determine networks that are behind the genetic basis of Type 2 diabetes. Alina is originally from San Diego, CA and loves anything to do with the outdoors— she loves running, backpacking and camping.
Welcome to the team Alina!
Anna Gloyn delivered a plenary talk as part of the International Common Disease Alliance (ICDA) Virtual Meeting on the 8th December.
Her presentation was in the session on Maps to Mechanisms and can be viewed on the ICDA YouTube channel.
Interested in learning more about going from a GWAS variant to molecular mechanism? Register for the Nature Genetics & Nature Genetics Reviews Podcast where Anna Gloyn & Manolis Kellis (MIT) discuss current progress in this area
Professor Gloyn to kick off Season 2 of the Virtual Diabetes Research Seminar Series (09/09/2020)
The Virtual Diabetes Research Center Seminar Series is an effort to connect investigators and trainees during this time of great change, anxiety, and isolation related to the COVID crisis. This pilot seminar series is organized by the NIDDK Diabetes Research Centers at the Albert Einstein College of Medicine, Indiana University in Indianapolis, Stanford University, the University of Alabama at Birmingham, the University of Michigan, the University of Colorado, the University of Washington, Vanderbilt University, and in North Carolina.
The seminar series will resume on Wednesday, September 9th, 2020 (2:00 PM EST | 1:00 PM CST | 12:00 PM MST | 11:00 AM PST) with a presentation by Professor Anna Gloyn (Stanford), “Using human genetics to unravel mechanisms of human islet-cell dysfunction in type 2 diabetes.”
Find out more and register for the seminar series here. https://www.vumc.org/diabetescenter/virtual-seminar-series
In February Anna & Nicole both officially started at Stanford and moved into their new space at 3165 Porter Drive. The lab is taking shape and we will be ready to get our research back up and running as the COVID19 shut down is lifted.
We have already welcomed team member Antje Grotz to Stanford for a visit.
You can read more about our relocation to Stanford in the Stanford Diabetes Research Centre Newsletter.